Audioboom logo
Menu
Audioboom logo
  • Podcasts
  • Advertisers
  • Creators
  • Help & support
  • Sign up
  • Sign in
Podcasts
Advertisers
Creators
Help & support
Search podcasts
Sign up
Sign in
Podcast logo
OncLive® On Air

Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC

Season 11, Episode 1,   Aug 08, 2024, 08:48 PM

Headliner
See more options
Share
Facebook X
Subscribe

Dr Rotow discusses data that demonstrated the central nervous system activity of datopotamab deruxtecan and osimertinib in patients with NSCLC.

Share
Facebook X
Subscribe
Next
ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo vs Adjuvant Nivo for Resectable Stage III Melanoma
Top episodes
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air
Wise Summarizes Survival Data From ARASENS and PEACE-1 in Prostate Cancer
by OncLive® On Air
  •   Report this episode
  •   Download audio
  •   QRCode
For podcasters For advertisers For listeners
Help & feedback About us Blog Investor relations
Cookie policy Privacy policy Terms & conditions
©2025 Audioboom

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

Page load failed

Please check your internet connection and refresh the page. You might also try disabling any ad blockers.

You can visit our support center if you're having problems.